{"id":"W3015035753","doi":"10.1016/j.jaip.2020.03.022","title":"Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial","year":2020,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada); Queen's University; Ottawa Allergy Research Corporation; University of Ottawa; Probity Medical Research; Memorial University of Newfoundland; Centre hospitalier de l'Université Laval; Lynde Centre for Dermatology; University of Toronto","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Omalizumab; Dosing; Clinical endpoint; Randomized controlled trial; Internal medicine; Clinical trial; Surgery; Immunoglobulin E; Antibody","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007321144,0.001154784,0.00285296,0.0002716794,0.0003601505,0.001009852,0.0006447794,0.001166278,0.003827784],"category_scores_gemma":[0.0008237232,0.0004214356,0.002798133,0.0002265311,0.0005411903,0.0008496415,0.0004200187,0.003619965,0.0007532322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006184684,"about_ca_system_score_gemma":0.0006203384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007527554,"about_ca_topic_score_gemma":0.001600068,"domain_scores_codex":[0.9997303,0.00008614892,0.00001809931,0.0000625602,0.00002265573,0.00008028569],"domain_scores_gemma":[0.9996217,0.0001054052,0.00007359748,0.00003223636,0.00002138551,0.0001455895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8711419,0.005381605,0.002729683,0.001593619,0.003486586,0.0001653499,0.00009236071,0.001077473,0.004193861,0.0003995746,0.003478694,0.1062593],"study_design_scores_gemma":[0.8944049,0.07507399,0.01955571,0.000410754,0.003424774,0.0003584404,0.00007545749,0.001641833,0.0008870269,0.000582872,0.003526072,0.00005824267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9618848,0.02964034,0.0004966166,0.001921018,0.0007802304,0.0006483205,0.0008911173,0.0001461816,0.003591432],"genre_scores_gemma":[0.9803383,0.010757,0.001291396,0.001873733,0.0006882404,0.0008773371,0.001398534,0.000029525,0.002745972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003827784,"threshold_uncertainty_score":0.01280522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02191510144459533,"score_gpt":0.3183907006324672,"score_spread":0.2964755991878719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}